Category Archives: Ophthalmology

Mobius brand Mitosol Recall

Share

Mobius brand Mitosol (mitomycin for solution) Kit for Ophthalmic Use: Recall-May Not be Sterile AUDIENCE: Ophthalmology ISSUE: Mobius Therapeutics announced that it is conducting a voluntary recall of 2 lots of Mitosol (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic … Continue reading

Share
Posted in FDA 2013, FDA Recall, Ophthalmology | Tagged , , , , , , , , | Comments Off on Mobius brand Mitosol Recall

Franck’s Lab Brilliant Blue Recall

Share

Franck’s Compounding Pharmacy Sterile Preparations: Reports of Fungal Endophthalmitis, Expanded Recall 5/24/2012 AUDIENCE: Ophthalmology, Urology, Primary Care, Pharmacy ISSUE: FDA is notifying all physicians and medical care organizations who have ordered any compounded product sold as a sterile preparation by … Continue reading

Share
Posted in FDA 2012, FDA Recall, Ophthalmology, Risk Manager | Tagged , , , , , | Comments Off on Franck’s Lab Brilliant Blue Recall

Brilliant Blue G Recall

Share

Brilliant Blue G: Recall of Unapproved Drug – Ongoing Investigation of Fungal Endophthalmitis Cases AUDIENCE: Ophthalmology, Risk Manager ISSUE: FDA has received reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G (BBG) during eye surgeries. Clinicians … Continue reading

Share
Posted in FDA 2012, FDA Recall, Ophthalmology, Risk Manager | Tagged , , , , , , , , , , , , | Comments Off on Brilliant Blue G Recall